BlackRock Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5K Hold
1,928
﹤0.01% 3760
2016
Q3
$7K Buy
1,928
+432
+29% +$1.98K ﹤0.01% 3695
2016
Q2
$6K Buy
1,496
+548
+58% +$2.54K ﹤0.01% 3797
2016
Q1
$5K Hold
948
﹤0.01% 3809
2015
Q4
$6K Hold
948
﹤0.01% 3818
2015
Q3
$4K Hold
948
﹤0.01% 3976
2015
Q2
$6K Buy
948
+280
+42% +$1.52K ﹤0.01% 3896
2015
Q1
$4K Hold
668
﹤0.01% 3889
2014
Q4
$5K Hold
668
﹤0.01% 3898
2014
Q3
$5K Buy
+668
New +$6.42K ﹤0.01% 3887

Other funds holding CDNA

BlackRock Investment Management's CDNA Position: Q4 2016 in Review

BlackRock Investment Management held its CareDx (CDNA) position steady in Q4 2016 at 1,928 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #3760.

BlackRock Investment Management first reported a position in CDNA in Q3 2014 and has held it in 10 quarters since. The position peaked at $7K in Q3 2016. 31 funds tracked by Wall St. Rank hold CDNA as of Q4 2016.

  • BlackRock Investment Management held 1,928 shares of CareDx worth $5K as of Q4 2016.
  • BlackRock Investment Management left its CareDx share count unchanged in Q4 2016.
  • CareDx made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3760 holding.
  • BlackRock Investment Management first reported a position in CareDx in Q3 2014 and has held it in 10 quarters since.
  • BlackRock Investment Management's CareDx position peaked at $7K in Q3 2016.
  • 31 funds tracked by Wall St. Rank held CareDx as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.